Show newer

Massive viral replication and cytopathic effects in early COVID-19 pneumonia. (arXiv:2005.00004v1 [q-bio.TO]) arxiv.org/abs/2005.00004

Heterogeneous social interactions and the COVID-19 lockdown outcome in a multi-group SEIR model. (arXiv:2005.00049v1 [q-bio.PE]) arxiv.org/abs/2005.00049

Software for Microscopy Workshop White Paper. (arXiv:2005.00082v1 [q-bio.OT]) arxiv.org/abs/2005.00082

A Systematic Approach to Featurization for Cancer Drug Sensitivity Predictions with Deep Learning. (arXiv:2005.00095v1 [cs.LG]) arxiv.org/abs/2005.00095

Effects of weather and policy intervention on COVID-19 infection in Ghana. (arXiv:2005.00106v1 [q-bio.PE]) arxiv.org/abs/2005.00106

Random tags can sustain high heterophily levels. (arXiv:2005.00389v1 [q-bio.PE]) arxiv.org/abs/2005.00389

Bacterial pathways for the biosynthesis of ubiquinone. (arXiv:2005.00394v1 [q-bio.BM]) arxiv.org/abs/2005.00394

A continuous-time state-space model for rapid quality-control of Argos locations from animal-borne tags. (arXiv:2005.00401v1 [q-bio.QM]) arxiv.org/abs/2005.00401

Protein-protein modelling using cryo-EM restraints. (arXiv:2005.00435v1 [q-bio.BM]) arxiv.org/abs/2005.00435

Manifold learning for brain connectivity. (arXiv:2005.00469v1 [q-bio.NC]) arxiv.org/abs/2005.00469

Manual segmentation versus semi-automated segmentation for quantifying vestibular schwannoma volume on MRI. (arXiv:2004.14462v1 [eess.IV]) arxiv.org/abs/2004.14462

Mixed volume of small reaction networks. (arXiv:2004.14467v1 [q-bio.MN]) arxiv.org/abs/2004.14467

COVID-19 and the difficulty of inferring epidemiological parameters from clinical data. (arXiv:2004.14482v1 [q-bio.QM]) arxiv.org/abs/2004.14482

Virus Dynamics with Behavioral Responses. (arXiv:2004.14533v1 [q-bio.PE]) arxiv.org/abs/2004.14533

Prediction of Epilepsy Development in Traumatic Brain Injury Patients from Diffusion Weighted MRI. (arXiv:2004.14580v1 [q-bio.QM]) arxiv.org/abs/2004.14580

Effect of Mitigation Measures on the Spreading of COVID-19 in Hard-Hit States. (arXiv:2004.14621v1 [q-bio.PE]) arxiv.org/abs/2004.14621

The first 100 days: modeling the evolution of the COVID-19 pandemic. (arXiv:2004.14664v1 [q-bio.PE]) arxiv.org/abs/2004.14664

Containment effort reduction and regrowth patterns of the Covid-19 spreading. (arXiv:2004.14701v1 [q-bio.PE]) arxiv.org/abs/2004.14701

How Often Should People be Tested for Corona to Avoid a Shutdown?. (arXiv:2004.14767v1 [q-bio.PE]) arxiv.org/abs/2004.14767

Refined compartmental models, asymptomatic carriers and COVID-19. (arXiv:2004.14780v1 [q-bio.PE]) arxiv.org/abs/2004.14780

Show older
Qoto Mastodon

QOTO: Question Others to Teach Ourselves
An inclusive, Academic Freedom, instance
All cultures welcome.
Hate speech and harassment strictly forbidden.